Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Statement

4 Feb 2020 07:00

RNS Number : 8239B
Electrocomponents PLC
04 February 2020
 

Electrocomponents plc today issues a trading update for the four-month period to 31 January 2020

 

Like-for-like revenue growth(1)

Region

Q1 to June 2019

H1 to Sept 2019

4 months to 31 Jan 2020

Northern Europe

7%

5%

3%

Southern Europe

5%

5%

3%

Central Europe

3%

2%

(4)%

Emerging markets

9%

33%

8%

Total EMEA

5%

5%

2%

Americas

0%

3%

2%

Asia Pacific

1%

2%

2%

Group

4%

5%

2%

 

·; Overall trading remains consistent with the first six weeks of H2. We continue to see modest growth and continued market share gains despite ongoing uncertainty in some of our key underlying markets.

o Industrial market share gains continued to offset ongoing softness in the Electronics market.

o All three regions remain in modest growth. Within EMEA, Central Europe was impacted by a continued slow performance in Germany.

o Trading continued to show some volatility from week to week especially around the calendar year end, however January was above the average for the period.

o RS PRO outperformed the Group with 10% like-for-like growth.

o Digital like-for-like revenue grew broadly in line with Group.

 

·; We continue to take actions to maintain, and where possible improve, gross margin. Given the impact of product mix and OKdo, we continue to expect a decline in gross margin for the full year.

 

DAVID EGAN, CHIEF FINANCIAL OFFICER, COMMENTED:

"During the first four months of H2 we have executed well, driving market share gains against an uncertain market backdrop. We continue to actively manage our operating costs, while increasing investment in strategic initiatives to position the business for the significant longer-term market opportunity. Whilst our markets are challenging, we remain well positioned to deliver good progress."

 

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Polly Elvin

VP Investor Relations

020 7239 8427

Martin Robinson / Lisa Jarrett Kerr

Tulchan Communications

020 7353 4200

 

Notes:

1. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions, changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2019 is converted at 2020 average exchange rates for the period.

2. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2019 for euro and US$ respectively were 1.13 and $1.31 respectively. Every 1 cent movement in the euro has a circa £1.4 million impact on annual profit. Every 1 cent movement in the US $ has a circa £0.5 million impact on annual profit.

3. In the year ending 31 March 2020 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with the year ended 31 March 2019.

 

 

 

 

 

 

 

 

 

 

 

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Tuesday 4 February

UK Time:

08.00 call

Telephone number:

UK: 0800 376 7922

International: +44 (0) 20 7192 8000

PIN:

8372579

Chair:

David Egan

Electrocomponents plc - Replay Dial in Instructions (available until Tuesday 18 February)

Telephone number:

+44 (0) 333 300 9785

PIN:

8372579

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFIAFSIVIII
Date   Source Headline
28th Jun 202110:00 amRNSNotice of Trading Update
25th Jun 20212:30 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
15th Jun 202112:00 pmRNSAnnual Financial Report
10th Jun 202111:00 amRNSDirector/PDMR Shareholding
1st Jun 20219:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results
24th May 20213:00 pmRNSHolding(s) in Company
4th May 20213:00 pmRNSDirector Declaration
4th May 20219:00 amRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20219:00 amRNSTotal Voting Rights
30th Mar 202110:00 amRNSNotice of Trading Update
18th Mar 20212:30 pmRNSDirector/PDMR Shareholding
10th Mar 202110:00 amRNSAdditional Listing
1st Mar 20214:00 pmRNSDirector Declaration
1st Mar 202110:00 amRNSTotal Voting Rights
1st Mar 20217:00 amRNSAcquisition of John Liscombe Limited
8th Feb 20217:00 amRNSTrading Statement
4th Feb 202110:00 amRNSHolding(s) in Company
2nd Feb 20212:30 pmRNSDirector/PDMR Shareholding
1st Feb 20219:01 amRNSBlock listing Interim Review
1st Feb 20219:00 amRNSTotal Voting Rights
27th Jan 202110:00 amRNSNotice of Trading Update
13th Jan 20217:00 amRNSCompletion of Synovos acquisition
4th Jan 202110:46 amRNSTotal Voting Rights
21st Dec 20202:30 pmRNSDirector/PDMR Shareholding
16th Dec 20209:30 amRNSHolding(s) in Company
15th Dec 20202:35 pmRNSHolding(s) in Company
11th Dec 202011:00 amRNSDirectorate Change
10th Dec 20204:17 pmRNSResults of the Placing
10th Dec 20207:20 amRNSRetail Offer via PrimaryBid.com
10th Dec 20207:18 amRNSProposed Placing of Ordinary Shares
10th Dec 20207:14 amRNSStrategically Attractive Acquisitions and Placing
4th Dec 202010:00 amRNSHolding(s) in Company
3rd Dec 20204:05 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
20th Nov 202010:30 amRNSDirector/PDMR Shareholding
20th Nov 202010:30 amRNSRefinancing of Group Debt facilities
17th Nov 20203:25 pmRNSHolding(s) in Company
17th Nov 20202:30 pmRNSAdditional Listing
12th Nov 202011:28 amRNSDirector/PDMR Shareholding
10th Nov 202010:00 amRNSDividend Declaration
10th Nov 20207:00 amRNSHalf-year Report
2nd Nov 202010:30 amRNSTotal Voting Rights
8th Oct 20207:00 amRNSTrading Statement
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 202010:00 amRNSTotal Voting Rights
21st Sep 202010:30 amRNSNotice of Trading Update
18th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.